Skip to main content

Table 1 ESAC drug-specific quality indicators for outpatient antibiotic use (Taken from Adriaenssens et al, 2011) [11]

From: Improving antimicrobial prescribing in Irish primary care through electronic data collection and surveillance: a feasibility study

Label

Description

J01_DID

consumption of antibacterials for systemic use (J01) expressed in DID

J01C_DID

consumption of penicillins (J01C) expressed in DID

J01D_DID

consumption of cephalosporins (J01D) expressed in DID

J01F_DID

consumption of macrolides, lincosamides and streptogramins (J01F) expressed in DID

J01M_DID

consumption of quinolones (J01M) expressed in DID

J01CE_%

consumption of β-lactamase-sensitive penicillins (J01CE) expressed as a percentagea

J01CR_%

consumption of combinations of penicillins, including β-lactamase inhibitors (J01CR) expressed as a percentagea

J01DD +  DE_%

consumption of third- and fourth-generation cephalosporins [J01(DD +  DE)] expressed as a percentagea

J01MA_%

consumption of fluoroquinolones (J01MA) expressed as percentagea

J01_B/N

ratio of the consumption of broad-{J01[CR +  DC  +  DD  +  (F-FA01)]} to the consumption of narrow-spectrum penicillins, cephalosporins and macrolides [J01(CE  +  DB  +  FA01)]

J01_SV

seasonal variation of total antibiotic consumption (J01)b

J01M_SV

seasonal variation of quinolone consumption (J01M)b

  1. aPercentage of total consumption of antibacterials for systemic use (J01) in DID
  2. bOveruse in the winter quarters (October–December and January–March) compared with the summer quarters (July–September and April–June) of a 1 year period starting in July and ending the next calendar year in June, expressed as a percentage: [DDD (winter quarters)/DDD (summer quarters) −1] × 100